![Specialty_banner](/th/sites/default/files/2023-07/Specialty.png)
Specialty
Boehringer Ingelheim specialty pioneering science inspired by patients we won’t rest until we can give people the chance to live the life they want.
ILDTalks PPF in CTD-ILD EP.4: How does nintedanib fit in with background treatments for underlying CTDs?
26/03/2024 | Author: Boehringer Ingelheim
Document ID: PC-TH-104592